Colorado · 2021-2022
FDA-approved Prescription 3,4-Methylenedioxymethamphetamine Drug Use
Read HB22-1344 at the Colorado legislature →
10 registered positions on this bill · 10 state a side.
| Lobbyist or firm | For client | Position | Session |
|---|---|---|---|
| Colorado Legislative Strategies | Colorado BioScience Association | Monitoring | 2021-2022 |
| Crews, Michael Anthony | Colorado BioScience Association | Monitoring | 2021-2022 |
| BRANDEBERRY MCKENNA PUBLIC AFFAIRS | Colorado Hospital Association | Monitoring | 2021-2022 |
| Ewing, Joshua | Colorado Hospital Association | Monitoring | 2021-2022 |
| MULREADY, KATHERINE | Colorado Hospital Association | Monitoring | 2021-2022 |
| WHITE, JOHN | Denver Department of Public Safety | Monitoring | 2021-2022 |
| Colorado Legislative Strategies | Emergent Biosolutions | Monitoring | 2021-2022 |
| Headwaters Strategies | MAPS Public Benefit Corporation | Supporting | 2021-2022 |
| Deborah A. Wagner, LLC | Mt Carmel Veterans Service Center | Monitoring | 2021-2022 |
| Keller, Maryanne "Moe" | mental health colorado | Monitoring | 2021-2022 |
Positions are as filed. A lobbyist may file more than once as a position changes.